Ginsenoside Rh2

For research use only. Not for therapeutic Use.

  • CAT Number: I004875
  • CAS Number: 78214-33-2
  • Molecular Formula: C36H62O8
  • Molecular Weight: 622.87
  • Purity: ≥95%
Inquiry Now

Ginsenoside Rh2(Cat No.:I004875)is a bioactive compound found in ginseng, a traditional herbal medicine known for its health benefits. It is a protopanaxadiol-type saponin derived from ginsenoside Rb1 and is primarily recognized for its potential anticancer, anti-inflammatory, and neuroprotective effects. Studies suggest that Ginsenoside Rh2 may inhibit tumor cell growth, induce apoptosis in cancer cells, and enhance immune function. Additionally, it has shown potential in improving cognitive function and reducing stress. However, more clinical research is needed to fully understand its therapeutic efficacy and safety profile.


Catalog Number I004875
CAS Number 78214-33-2
Molecular Formula C36H62O8
Purity ≥95%
Target Metabolic Enzyme/Protease
Solubility 10 mM in DMSO
Storage 2-8°C
IUPAC Name (2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
InChI InChI=1S/C36H62O8/c1-20(2)10-9-14-36(8,42)21-11-16-35(7)27(21)22(38)18-25-33(5)15-13-26(32(3,4)24(33)12-17-34(25,35)6)44-31-30(41)29(40)28(39)23(19-37)43-31/h10,21-31,37-42H,9,11-19H2,1-8H3/t21-,22+,23+,24-,25+,26-,27-,28+,29-,30+,31-,33-,34+,35+,36-/m0/s1
InChIKey CKUVNOCSBYYHIS-IRFFNABBSA-N
SMILES CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C)C)O)C)O)C
Reference

<p style=/line-height:25px/>
<br>[1]. Yan Zhu, et al. Ginsenoside Rh2 suppresses growth of uterine leiomyoma in vitro and in vivo and may regulate ERα/c-Src/p38 MAPK activity. Journal of Functional Foods
Volume 18, Part A, October 2015, Pages 73–82

<br>[2]. Shaoyi Li, et al. Ginsenoside Rh2 inhibits invasiveness of glioblastoma through modulation of VEGF-A. Tumor Biology
July 2015

<br>[3]. Ning Guan, et al. Ginsenoside Rh2 inhibits metastasis of glioblastoma multiforme through Akt-regulated MMP13. Tumor Biology,
April 2015

<br>[4]. Zhou J, et al. Ginsenoside Rh2 Suppresses Neovascularization in Xenograft Psoriasis Model. Cell Physiol Biochem 2015;36:980-987

</p>

Request a Quote